Stockreport

Neovasc Receives Approval to Proceed with Phase 2 of TIARA-II Study from Clinical Regulators in Germany and the UK

Neovasc Inc. - Common Shares  (NVCN) 
Last neovasc inc. - common shares earnings: 3/30 04:08 pm Check Earnings Report
US:NASDAQ Investor Relations: neovasc.com/neovasc-investment/overview
PDF Successfully completed all Phase 1 requirements of TIARA-IINASDAQ, TSX: NVCN VANCOUVER, Jan 29, 2019 /PRNewswire/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: N [Read more]